X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Neuromodulation Companies (2024 - 2029)

Several prominent companies in the medical field are making significant strides in their respective areas. These firms are known for their innovative approaches and ground-breaking research, which are making a tangible difference in the lives of patients worldwide. From developing cutting-edge medical devices to pioneering new treatment methods, these corporations are at the forefront of medical advancements. Their commitment to improving healthcare and patient outcomes is commendable, proving their status as industry leaders in the global market.

Home Market Analysis Healthcare Research Device Drug Combination Research Co-Packages Research Therapeutic Systems Research Electro Therapy Research Neuromodulation Market Companies

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Top Companies in Neuromodulation Market

This report lists the top Neuromodulation companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Neuromodulation industry.

  1. Boston Scientific

  2. Abbott Laboratories

  3. Synapse Biomedical

  4. Medtronic

  5. Nevro

*Disclaimer: Top companies sorted in no particular order

Neuromodulation Market Major Players

Neuromodulation Market Concentration

Neuromodulation Market Concentration

Neuromodulation Company List

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Prevalence of Neurological Disorders

      2. 4.2.2 Increase in the Aging Population

      3. 4.2.3 New Indications and Expanded Target Applications

    3. 4.3 Market Restraints

      1. 4.3.1 Inconsistent Reimbursement Policies

      2. 4.3.2 Lack of Trained Professionals

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value )

    1. 5.1 By Technology

      1. 5.1.1 Internal Neuromodulation

        1. 5.1.1.1 Spinal Cord Stimulation (SCS)

        2. 5.1.1.2 Deep Brain Stimulation (DBS)

        3. 5.1.1.3 Vagus Nerve Stimulation (VNS)

        4. 5.1.1.4 Sacral Nerve Stimulation (SNS)

        5. 5.1.1.5 Gastric Electrical Stimulation (GES)

      2. 5.1.2 External Neuromodulation (Non-invasive)

        1. 5.1.2.1 Transcutaneous Electrical Nerve Stimulation (TENS)

        2. 5.1.2.2 Transcranial Magnetic Stimulation (TMS)

        3. 5.1.2.3 Other External Neuromodulations

    2. 5.2 By Application

      1. 5.2.1 Parkinson's Disease

      2. 5.2.2 Epilepsy

      3. 5.2.3 Depression

      4. 5.2.4 Dystonia

      5. 5.2.5 Pain Management

      6. 5.2.6 Other Applications

    3. 5.3 By Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Boston Scientific Corporation

      3. 6.1.3 Medtronic PLC

      4. 6.1.4 Nevro Corporation

      5. 6.1.5 Neuropace Inc.

      6. 6.1.6 Neurosigma Inc.

      7. 6.1.7 Neuronetics Inc.

      8. 6.1.8 LivaNova PLC

      9. 6.1.9 Nuvectra

      10. 6.1.10 Synapse Biomedical Inc.

      11. 6.1.11 Bioness

      12. 6.1.12 Soterix Medical

    2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS


Specific to Neuromodulation Market
Need More Details On Market Players And Competitors?
Download PDF

Competitive Landscape Report Includes

Company Profiles (includes Global Level Overview, Market Level Overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and Analysis of Recent Developments). Key Strategic Moves, Market Share Analysis, Company Landscape, and List of Companies.

Neuromodulation Market Companies Summary

The neuromodulation market has seen a significant impact due to the COVID-19 pandemic, with many procedures being postponed due to government restrictions. However, the demand for neuromodulation increased in 2021, as studies suggested that patients with chronic COVID-19 symptoms benefited from these devices. This increased adoption of neuromodulation procedures, despite the onset of various strains of the virus and associated post-COVID symptoms. The rising prevalence of neurological disorders, the aging population, and new indications and expanded target applications are anticipated to drive the overall market growth. The burden of neurological diseases has led many firms in the market to focus on the development of neuromodulation products, creating a competitive environment. The availability of various products is expected to lead to a surge in market demand. However, inconsistent reimbursement policies and a lack of trained professionals are expected to hinder market growth. The deep brain stimulation (DBS) segment is predicted to hold a significant share of the market during the analysis period, with manufacturers developing a new generation of devices and enhancing their current DBS systems. These advancements have led to an increase in the adoption of DBS, driving market growth.

Explore More

Neuromodulation Companies - Table of Contents

  1. 1. COMPETITIVE LANDSCAPE

    1. 1.1 Company Profiles

      1. 1.1.1 Abbott Laboratories

      2. 1.1.2 Boston Scientific Corporation

      3. 1.1.3 Medtronic PLC

      4. 1.1.4 Nevro Corporation

      5. 1.1.5 Neuropace Inc.

      6. 1.1.6 Neurosigma Inc.

      7. 1.1.7 Neuronetics Inc.

      8. 1.1.8 LivaNova PLC

      9. 1.1.9 Nuvectra

      10. 1.1.10 Synapse Biomedical Inc.

      11. 1.1.11 Bioness

      12. 1.1.12 Soterix Medical

    2. *List Not Exhaustive

Neuromodulation Companies FAQs

Boston Scientific Corporation, Abbott Laboratories, Synapse Biomedical Inc., Medtronic PLC and Nevro Corporation are the major companies operating in the Neuromodulation Market.

Neuromodulation Market Report Snapshots

Neuromodulation Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)